HONG KONG, Sept. 6, 2011 /PRNewswire-Asia-FirstCall/ — China
Cord Blood Corporation (NYSE:
CO) (“CCBC” or the “Company”), China’s leading provider of cord
blood collection, laboratory testing, hematopoietic stem cell
processing, and stem cell storage services, today announced that
the Company will participate in the following investor
The Morgan Stanley Global Healthcare Conference, to be held
September 13-14, 2011 at the Grand Hyatt New York, and the Morgan
Stanley China Healthcare Day, to be held September 15, 2011 at the
Four Seasons Hotel in Boston. Management is scheduled to present
and to meet with institutional investors throughout both days of
both conferences. The UBS Global Life Sciences Conference, to be
held September 19-21, 2011 at the Grand Hyatt New York. Management
is scheduled to present and to meet with institutional investors
throughout the first two days of the conference.
For further details, please contact your respective
institutional sales representatives.
About China Cord Blood CorporationChina Cord Blood
Corporation is the first and largest cord blood banking operator in
China in terms of geographical coverage and is the only cord blood
banking operator with multiple licenses. Under current PRC
government regulations, only one licensed cord blood banking
operator is permitted to operate in each licensed region and only
seven licenses have been authorized as of today. China Cord Blood
Corporation provides cord blood collection, laboratory testing,
hematopoietic stem cell processing and stem cell storage services.
For more information, please visit our website at http://www.chinacordbloodcorp.com.
For more information, please contact:China Cord Blood
CorporationMs. Joeling LawTel: +852-3605-8180Email: